Keyword: Ablynx

Using broadly neutralizing single-domain antibodies from llamas, scientists have designed a vaccine that can potentially combat almost all flu viruses.

Ablynx CMO Robert Zeldin is moving to Acceleron, to take over for longtime CMO Matthew Sherman, as it begins to get phase 3 data on luspatercept.

Ex-Millennium chief named CEO of Lundbeck; Ablynx's CMO to take post at Acceleron; and PredictImmune appoints new CEO.

Sanofi says its GLP-1 drug SAR425899 is undertaking new tests to try to get around dosing issues that is causing GI problems.

The $400 million deal gives Novo worldwide rights to an epigenetic treatment of the disease that is closing in on the start of a phase 2 trial.

The setback tarnishes one of the drugs Sanofi is set to acquire through its €3.9 billion takeover of Ablynx.

Sanofi’s €45-a-share cash bid enabled it to leapfrog Novo Nordisk in the race to buy Ablynx and land its second big-ticket takeover of the month. 

NICE leader joined ABPI; Heptares co-founder will lead Merck’s new London center; Sanofi named a business transformation head.

Van Herk Investments thinks Novo’s recent offer was too low, but it will encourage Ablynx to enter talks if a sufficiently sweetened bid is received.